Milwaukee、WIにおけるバーキットリンパ腫の臨床試験

Milwaukeeとその周辺地域（約30マイル以内）の拠点で、バーキットリンパ腫に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト（英語）

ここで研究参加者を募集していますか？このページの上部に表示できます — 30日間 $99 →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

被験者募集中第2相

Children's Hospital of Wisconsin, Milwaukee

366 Days – 46 Years · 全性別 · 2026/10/02更新 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

被験者募集中第3相

Medical College of Wisconsin, Milwaukee

18歳〜39歳 · 全性別 · 2026/10/02更新 · NCT03150693

Blinatumomab Consolidation in Real World

被験者募集中観察研究健康なボランティア歓迎

Medical College of Wisconsin, Milwaukee

18歳以上 · 全性別 · 2026/10/01更新 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

被験者募集中観察研究

Children's Hospital of Wisconsin, Milwaukee

0歳〜38歳 · 全性別 · 2026/10/01更新 · NCT06131801

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

被験者募集中第2相

Medical College of Wisconsin, Milwaukee
Drexel Town Square Health Center, Oak Creek · 11マイル先
Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11マイル先
他1件

18歳以上 · 全性別 · 2026/09/29更新 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

被験者募集中第2相

Children's Hospital of Wisconsin, Milwaukee

365 Days · 全性別 · 2026/09/25更新 · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

被験者募集中第3相

Medical College of Wisconsin, Milwaukee

18歳以上 · 全性別 · 2026/09/21更新 · NCT07648264

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

被験者募集中第1相

Medical College of Wisconsin, Milwaukee

18歳以上 · 全性別 · 2026/09/08更新 · NCT03666000

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

被験者募集中第2相

Children's Hospital of Wisconsin, Milwaukee

1歳〜30歳 · 全性別 · 2026/09/01更新 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

被験者募集中第3相

Children's Hospital of Wisconsin, Milwaukee

365 Days – 25 Years · 全性別 · 2026/08/25更新 · NCT03959085

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

被験者募集中第1/2相

Research Site, Milwaukee

12歳以上 · 全性別 · 2026/08/19更新 · NCT06137118

LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies

被験者募集中第1相

Froedtert & the Medical College of Wisconsin, Milwaukee

18歳〜81歳 · 全性別 · 2026/08/06更新 · NCT05990465

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

被験者募集中

Children's Wisconsin, Milwaukee

0歳〜25歳 · 全性別 · 2026/05/13更新 · NCT05794880

Study of SGR-1505 in Mature B-Cell Neoplasms

被験者募集中第1相

Medical College of Wisconsin, Milwaukee

18歳以上 · 全性別 · 2026/02/13更新 · NCT05544019

Long-term Follow-up Study of Patients Receiving CAR-T Cells

被験者募集中観察研究

Froedtert Hospital & Medical College of Wisconsin, Milwaukee

18歳〜80歳 · 全性別 · 2025/11/10更新 · NCT03375619

Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT

被験者募集中第2相

Children's Hospital of Wisconsin, Milwaukee

25歳以下 · 全性別 · 2021/09/17更新 · NCT04746209

他の都市におけるバーキットリンパ腫の試験

Milwaukeeにおける他の研究

ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。